A recent insider purchase by the CEO and a slight uptick in a major institutional holding are providing a counter-narrative to prevailing market skepticism around Hensoldt. The central question for investors is no longer about demand, but rather the pace at which the company’s record order backlog can be converted into tangible revenue.
Leadership and Institutional Confidence
CEO Oliver Dörre recently acquired 1,000 shares at an average price of €75.25, representing a total investment of €75,250. This transaction followed what market sources described as a tepid reaction to the company’s annual results. In a separate but concurrent development, an updated filing on March 3 showed BlackRock’s stake increased to 5.06%, up from 5.01%. This position comprises 2.96% in directly held shares and 2.09% held through financial instruments. While these are incremental moves, they stand out against a backdrop of recent investor caution.
The Disconnect Between Orders and Revenue
Operationally, Hensoldt reported a record order intake of €4.71 billion for the fiscal year, a substantial 62% increase year-over-year. Consequently, the total order backlog swelled to €8.83 billion, marking a 33% rise and significantly surpassing annual revenue. Key growth drivers included air defense radar systems, the Eurofighter program, and the P8 Poseidon aircraft.
Revenue growth, however, told a different story, expanding at a more moderate 9.6% to reach €2.455 billion. On a positive note, adjusted EBITDA hit €452 million, with the corresponding margin of 18.4% exceeding the company’s minimum target of 18%. Adjusted free cash flow also saw a healthy increase, rising to €347 million.
The core issue, which management has explicitly identified, is one of capacity constraints. Demand is clearly robust, but the translation of orders into deliveries and revenue is not progressing at the desired speed. This bottleneck is now the defining factor for the company’s outlook in 2026.
2026 Forecasts and Strategic Expansion
Looking ahead, Hensoldt has provided guidance for 2026, projecting revenue of approximately €2.75 billion and an adjusted EBITDA margin between 18.5% and 19%. Market analysts note that the midpoint of this revenue forecast sits about two percent below the current consensus estimate. Management has reaffirmed its target for a book-to-bill ratio of 1.5x to 2.0x, underscoring that execution—not a lack of demand—remains the critical challenge.
To address this, the company plans to create around 1,600 new positions in 2026, which would expand its current workforce of approximately 9,000 employees by nearly 18%. Furthermore, capital expenditures totaling roughly €1 billion are scheduled between 2025 and 2027, primarily aimed at expanding capacity for German defense contracts. In a show of confidence in its leadership, the supervisory board has extended Oliver Dörre’s contract ahead of schedule through the end of 2031.
Despite these plans, the share price reflects ongoing pressure. Shares recently closed at €73.75, trading about 11.5% below the 50-day moving average of €83.31 and approximately 35.9% below the 52-week high of €115.10.
Investors now await key upcoming milestones. The audited group financial statements are expected on March 26, 2026, followed by first-quarter 2026 results on May 6, 2026. These reports will be critical in assessing whether the capacity expansion is beginning to yield measurable results in the form of higher delivery rates and incremental revenue growth.